OCULAR THERAPEUTIX INC (OCUL) Institutional Shareholders
OCULAR THERAPEUTIX INC (OCUL) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.88B in OCUL holdings during the latest filing period.
Fmr Llc is currently the largest disclosed institutional shareholder of OCUL tracked by InsiderSet, reporting ownership valued at approximately $322.53M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $331.72M, representing an estimated gain of +2.85% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed OCUL value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Deep Track Capital, Lp, and several other long-term asset managers with concentrated positions in OCULAR THERAPEUTIX INC (OCUL).
This page ranks the largest institutional OCUL shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
256
Total Reported Value
$1.88B
Largest Holder
Fmr Llc
Largest Position
$322.53M
Insider Transactions (90d)
14
Latest Filing Quarter
Q2 2026
New Institutional Positions
56
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Fmr Llc | 0.01% | 32,844,043 | $322,528,499 | $331,724,834 | +$9,196,335 | +2.85% | |
| Blackrock, Inc. | 0.00% | 19,376,555 | $190,277,772 | $195,703,206 | +$5,425,434 | +2.85% | |
| Deep Track Capital, Lp | 3.44% | 19,686,282 | $166,742,809 | $198,831,448 | +$32,088,639 | +19.24% | |
| Summer Road Llc | 74.46% | 12,208,296 | $119,885,466 | $123,303,790 | +$3,418,324 | +2.85% | |
| Avoro Capital Advisors Llc | 1.03% | 12,315,000 | $104,308,050 | $124,381,500 | +$20,073,450 | +19.24% | |
| Venrock Adviser, Llc | 3.27% | 10,346,926 | $87,638,463 | $104,503,953 | +$16,865,490 | +19.24% | |
| Vanguard Capital Management Llc | 0.00% | 8,832,595 | $86,736,083 | $89,209,210 | +$2,473,127 | +2.85% | |
| State Street Corp | 0.00% | 5,233,282 | $51,390,829 | $52,856,148 | +$1,465,319 | +2.85% | |
| Alliancebernstein L.P. | 0.02% | 4,129,687 | $50,134,400 | $41,709,839 | -$8,424,561 | -16.80% | |
| Geode Capital Management, Llc | 0.00% | 5,021,092 | $49,315,115 | $50,713,029 | +$1,397,914 | +2.83% | |
| Point72 Asset Management, L.P. | 0.08% | 5,534,985 | $46,881,323 | $55,903,349 | +$9,022,026 | +19.24% | |
| Logos Global Management Lp | 1.68% | 3,850,000 | $32,609,500 | $38,885,000 | +$6,275,500 | +19.24% | |
| Dimensional Fund Advisors Lp | 0.00% | 2,783,367 | $27,334,041 | $28,112,007 | +$777,966 | +2.85% | |
| Octagon Capital Advisors Lp | 2.97% | 3,166,600 | $26,821,102 | $31,982,660 | +$5,161,558 | +19.24% | |
| Balyasny Asset Management L.P. | 0.04% | 2,692,622 | $22,806,508 | $27,195,482 | +$4,388,974 | +19.24% | |
| Commodore Capital Lp | 1.26% | 2,575,000 | $21,810,250 | $26,007,500 | +$4,197,250 | +19.24% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,973,130 | $19,376,137 | $19,928,613 | +$552,476 | +2.85% | |
| Northern Trust Corp | 0.00% | 1,799,426 | $17,670,364 | $18,174,203 | +$503,839 | +2.85% | |
| Nuveen, Llc | 0.00% | 1,697,274 | $16,667,230 | $17,142,467 | +$475,237 | +2.85% | |
| Two Sigma Investments, Lp | 0.01% | 1,830,159 | $15,501,447 | $18,484,606 | +$2,983,159 | +19.24% | |
| Ubs Group Ag | 0.00% | 1,551,001 | $15,230,829 | $15,665,110 | +$434,281 | +2.85% | |
| Woodline Partners Lp | 0.05% | 1,667,609 | $14,124,648 | $16,842,851 | +$2,718,203 | +19.24% | |
| Tcg Crossover Management, Llc | 0.40% | 1,647,752 | $13,956,459 | $16,642,295 | +$2,685,836 | +19.24% | |
| Invesco Ltd. | 0.00% | 1,536,779 | $13,016,517 | $15,521,468 | +$2,504,951 | +19.24% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,289,200 | $12,659,944 | $13,020,920 | +$360,976 | +2.85% | |
| Defilade Capital Management, L.P. | 1.77% | 1,487,645 | $12,600,353 | $15,025,215 | +$2,424,862 | +19.24% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,461,177 | $12,376,169 | $14,757,888 | +$2,381,719 | +19.24% | |
| Goldman Sachs Group Inc | 0.00% | 1,110,366 | $9,404,800 | $11,214,697 | +$1,809,897 | +19.24% | |
| Morgan Stanley | 0.00% | 911,831 | $8,954,187 | $9,209,493 | +$255,306 | +2.85% | |
| Candriam S.C.A. | 0.04% | 907,839 | $8,906,402 | $9,169,174 | +$262,772 | +2.95% | |
| Empire Life Investments Inc. | 0.48% | 871,692 | $8,560,015 | $8,804,089 | +$244,074 | +2.85% | |
| Squarepoint Ops Llc | 0.02% | 980,757 | $8,307,012 | $9,905,646 | +$1,598,634 | +19.24% | |
| Sio Capital Management, Llc | 1.18% | 968,597 | $8,204,017 | $9,782,830 | +$1,578,813 | +19.24% | |
| Cetera Investment Advisers | 0.01% | 785,732 | $7,715,885 | $7,935,893 | +$220,008 | +2.85% | |
| Readystate Asset Management Lp | 0.44% | 883,621 | $7,484,270 | $8,924,572 | +$1,440,302 | +19.24% | |
| Peregrine Capital Management Llc | 0.24% | 753,495 | $7,399,321 | $7,610,300 | +$210,979 | +2.85% | |
| Raymond James Financial Inc | 0.00% | 859,485 | $7,279,838 | $8,680,799 | +$1,400,961 | +19.24% | |
| Jane Street Group, Llc | 0.01% | 804,589 | $6,814,868 | $8,126,349 | +$1,311,481 | +19.24% | |
| Aptus Capital Advisors, Llc | 0.05% | 638,691 | $6,271,946 | $6,450,779 | +$178,833 | +2.85% | |
| Second Line Capital, Llc | 1.17% | 638,640 | $6,271,445 | $6,450,264 | +$178,819 | +2.85% | |
| Algert Global Llc | 0.07% | 592,309 | $5,816,474 | $5,982,321 | +$165,847 | +2.85% | |
| Bank Of New York Mellon Corp | 0.00% | 553,236 | $5,432,780 | $5,587,684 | +$154,904 | +2.85% | |
| Citadel Advisors Llc | 0.00% | 635,922 | $5,386,259 | $6,422,812 | +$1,036,553 | +19.24% | |
| Tudor Investment Corp Et Al | 0.03% | 614,378 | $5,203,782 | $6,205,218 | +$1,001,436 | +19.24% | |
| Knoll Capital Management, Llc | 2.82% | 600,400 | $5,085,388 | $6,064,040 | +$978,652 | +19.24% | |
| Opaleye Management Inc. | 0.67% | 600,000 | $5,082,000 | $6,060,000 | +$978,000 | +19.24% | |
| Acuta Capital Partners, Llc | 3.57% | 592,108 | $5,015,155 | $5,980,291 | +$965,136 | +19.24% | |
| Jpmorgan Chase & Co | 0.00% | 482,293 | $4,858,138 | $4,871,159 | +$13,021 | +0.27% | |
| Essex Investment Management Co Llc | 0.62% | 482,154 | $4,734,752 | $4,869,755 | +$135,003 | +2.85% | |
| Qube Research & Technologies Ltd | 0.01% | 531,816 | $4,504,482 | $5,371,342 | +$866,860 | +19.24% |
Frequently asked questions about OCUL
Who owns the most OCUL stock?
The largest holders of OCUL are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for OCULAR THERAPEUTIX INC (OCUL).
Is OCUL widely held by superinvestors?
Many widely followed stocks like OCUL appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly OCUL is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.